To the Editor: After having read the article "Prognosis in Hyaline-Membrane Disease" by Dr. Mildred Stahlman and her associates in the February 9 issue of the Journal. I found it interesting to ...

Her primary focus was on hyaline membrane disease, sometimes called respiratory distress syndrome, in which alveoli — tiny air sacs in the lungs — do not properly inflate. The condition almost ...

Endothelin-1; Respiratory distress syndrome; Prematurity; Hyaline membrane disease; Pulmonary hypertension ... more than 40% oxygen to keep a hemoglobin saturation of 92%, a chest X-ray study showing ...

This unsettling event has reignited discussions about “Disease X.” Disease X is not an actual but a hypothetical disease. The World Health Organization (WHO) coined the term in 2018 to ...

Anti-glomerular basement membrane (anti-GBM) disease, also known as Goodpasture disease, is a rare, severe autoimmune condition affecting around 1.6 people per million annually1 with majority of ...

Seventy infants who had clinical hyaline-membrane disease as neonates were followed from two to five years with repeated physical examinations and x-ray films of the chest. Nineteen of them had ...

When a baby is born prematurely, he is especially susceptible to a breathing difficulty that develops into hyaline membrane disease. The inner linings of the lungs get covered with a membrane that ...

Because the membrane looks glassy, this condition is called hyaline (from the Greek for glassy) membrane disease. But the pathologist who does a post-mortem examination on a baby is the only man ...

In 1954, after receiving a grant from the National Institute of Health to study hyaline membrane disease, her and her team developed ways to diagnose and monitor the disease. Around the same time ...

“She was struck by the fact that some babies who were close to term, not premature, had hyaline membrane disease,” the former name for respiratory distress syndrome, said Dr. Hakan ...

When this happens, you might have what’s called an autoimmune disease, Konstantin Balashov, MD, PhD, the director of the Boston Medical Center Multiple Sclerosis Center, tells SELF. But ...